Skip to main content
Equibles
HROW logo

HROW · Harrow, Inc. · Metrics

Track HROW — free

Use HROW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HROW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$28.24 +0.17 (+0.61%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$1.06B
Shares
37.49M
Volume · Oct 21 524.14K Avg daily vol (3M) 567.1K

HROW metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$28.24
Market cap
$1.06B

Price action

20 metrics
Price change (1W)
-0.6%
Price change (30D)
-17.2%
Price change (3M)
-35.8%
Price change (6M)
-28.8%
Price change (YTD)
-42.7%
Price change (1Y)
-33.4%
Trailing year
Price change (5Y)
+179.3%
52-week high
$54.80
52-week low
$27.24
Change from 52-week high
-48.8%
Change from 52-week low
+3.0%
Annualized volatility
62.6%
Annualized volatility (3M)
42.0%
Beta
1.4
RSI (14D)
32.9
Price vs SMA 50
-19.0%
Price vs SMA 200
-28.4%
Avg volume (3M)
570,724
Relative volume
0.9
Average dollar volume
$20.24M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
37.49M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
4.6×
reciprocal yield 21.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
3.8×
reciprocal yield 26.2%
P / book
69.2
reciprocal yield 1.4%
FCF yield
0.5%
TTM · current market cap
Buyback yield
—
P / FCF
209.8
reciprocal yield 0.5%
P / operating cash flow
168.3
reciprocal yield 0.6%
Earnings yield
-3.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
5.9×
reciprocal yield 17.0%
EV / revenue historical average (5Y)
5.3×
reciprocal yield 19.0%
EV / EBIT historical average (3Y)
264.1×
reciprocal yield 0.4%
EV / EBIT historical average (5Y)
249.0×
reciprocal yield 0.4%
EV / EBITDA historical average (3Y)
99.3×
reciprocal yield 1.0%
EV / EBITDA historical average (5Y)
7,972.6×
reciprocal yield 0.0%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
73.3%
Operating margin
-1.0%
Trailing 12 months
Net margin
-13.5%
Gross profit (TTM)
$201.96M
Operating profit (TTM)
−$2.75M
Net income (TTM)
−$37.23M
Trailing 12 months
Diluted EPS (TTM)
$-0.97
FCF margin
1.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.41

Growth

11 metrics
Revenue growth YoY
+10.9%
Year over year
Net income growth YoY
-445.7%
Revenue (TTM)
$275.59M
Trailing 12 months
EPS growth YoY
-453.8%
Shares change YoY
-3.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+45.4%
Revenue CAGR (5Y)
+41.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-244.9%
Return on assets
-8.9%
Debt / equity
10.5
Current ratio
2.2
EBITDA (TTM)
−$1.33M
Free cash flow (TTM)
$5.02M
Quick ratio
2.1
Interest coverage
-0.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$205.36M
Latest balance sheet
Cash & equivalents
$83.89M
Total assets
$416.82M
Total debt
$300.00M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$6.25M
Capital expenditures (TTM)
$1.24M
R&D (TTM)
$29.01M
SG&A (TTM)
$175.69M
Stock compensation (TTM)
$14.70M
R&D / revenue
10.5%
Stock compensation / revenue
5.3%

Ownership (13F)

9 metrics
13F filers
224
13F filer change QoQ
+3
Institutional ownership
62.2%
Conviction holders (share of 13F filers)
2.2%
Crowding (high-turnover and private-fund holders)
22.8%
Private-fund adviser ownership
21.5%
Active holders' share change QoQ
+0.7%
Holder tenure
11.6
Price vs estimated holder cost
+57.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
12.8%

Short interest

3 metrics
Short interest
20.7%
Latest settlement · 12.4 days to cover
Days to cover
12.4d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$450,000
Insider-sentiment score
40 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1360214 CUSIP 415858109 13F (30d) 27 filings 27 filers Visit website Investor relations